Physician

Albara Said, M.D.

According to 2025 Medicare claims, Albara Said, M.D. (NPI: 1013208412) practices nephrology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Cook, IL. This provider's primary affiliated billing organization is KIDNEY CARE CENTER OLYMPIA FIELDS LLC (NPI: 1619389715; TIN: 465577073) and primary practice location at 60461-1010. Said is affiliated with the Advocate Physician Partners Accountable Care, Inc. (ACO ID: A1033), participating under the MSSP model.

Said's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 327 traditional Medicare patients, billed 1,713 HCPCS/CPT codes, and received $161,193 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 806 prescription claims across 129 beneficiaries totaling $72,844 in drug costs, led by Farxiga (Dapagliflozin Propanediol). Open Payments data shows 5 records totaling $129. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $371 to $72,844. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	52	99	$7,159
2016	N/R	N/R	N/R
2017	172	577	$58,666
2018	465	1,451	$147,673
2019	436	1,617	$158,211
2020	586	3,184	$311,063
2021	556	3,048	$294,811
2022	440	2,697	$254,400
2023	352	2,061	$211,464
2024	327	1,713	$161,193

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	25	$371
2016	15	62	$10,012
2017	29	85	$16,808
2018	57	192	$11,287
2019	71	494	$30,462
2020	98	612	$35,526
2021	119	759	$27,285
2022	120	705	$54,926
2023	122	766	$60,990
2024	129	806	$72,844

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	139	153	$131
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	189	595	$95
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	33	51	$90
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	74	135	$73
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	65	123	$13

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Farxiga	Dapagliflozin Propanediol	19	810	$15,838
Jardiance	Empagliflozin	16	636	$12,431
Cinacalcet Hcl	Cinacalcet Hcl	16	600	$5,148
Sevelamer Carbonate	Sevelamer Carbonate	37	2,100	$4,132
Torsemide	Torsemide	118	8,226	$1,882

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	5	$129	Mallinckrodt Hospital Products Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Albara Said, M.D.?

Tedicare shows public-source Medicare data for Albara Said, M.D. (NPI 1013208412), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Albara Said, M.D. have ACO affiliation data?

Albara Said, M.D. is shown with ACO affiliation data for Advocate Physician Partners Accountable Care, Inc. (MSSP, ACO ID A1033).

What billing organization is linked to Albara Said, M.D.?

Albara Said, M.D. is linked to KIDNEY CARE CENTER OLYMPIA FIELDS LLC (billing NPI 1619389715) in the available physician profile data.

Does Albara Said, M.D. have Open Payments data?

Albara Said, M.D. has 5 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.